Vnitr Lek 2020, 66(4):249-252 | DOI: 10.36290/vnl.2020.069

Microscopic polyangiitis

Daniel Tobiáš, Kristína Brázdilová, Zdenko Killinger, Juraj Payer
V. interná klinika LF UK a UN Bratislava, Nemocnica Ružinov, Slovenská republika

Microscopic polyangiitis is a rare, systemic, necrotizing, pauci-immune, ANCA associated small vessel vasculitis, with no evidence of granulomatous inflammation. Diagnosing microscopic polyangiitis is often difficult because of it´s presentation by a number of non-specific symptoms. We treated a 35-year old patient, who was admitted for migrating arthritis and fever with papulous rash. In this case, we want to point out the importance of considering the diagnosis of MPA and similar rare diseases in the process of differential diagnosis, mainly in patients presenting with non-specific symptoms, because the mortality of this disease without adequate treatment is alarmingly high.

Keywords: ANCA, cerebritis, glomerulonephritis, pancreatitis, polyangiitis, vasculitis.

Published: June 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tobiáš D, Brázdilová K, Killinger Z, Payer J. Microscopic polyangiitis. Vnitr Lek. 2020;66(4):249-252. doi: 10.36290/vnl.2020.069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chung SA, Seo P Microscopic polyangiitis. Rheum Dis Clin North Am 2010; 36: 545-558. Go to original source... Go to PubMed...
    2. Fries JF, Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990; 33: 1135-1136. Go to original source... Go to PubMed...
    3. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37: 187-192. Go to original source... Go to PubMed...
    4. Lightfoot RW, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-1093. Go to original source... Go to PubMed...
    5. Amezcua‑Guerra LM, Prieto P, Bojalil R et al. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association? J Rheumatol 2006; 33: 2351-2353. Go to PubMed...
    6. Seligman VA, Bolton PB, Sanchez HC et al. Propylthiouracil‑induced microscopic polyangiitis. J Clin Rheumatol 2001; 7: 170-174. Go to original source... Go to PubMed...
    7. Altaie R, Ditizio F, Fahy GT Microscopic polyangitis presenting with sub‑acute reversible optic neuropathy. Eye (Lond.) 2005; 19: 363-365. Go to original source... Go to PubMed...
    8. Nagai Y, Hasegawa M, Igarashi N et al. Cutaneous manifestations and histological features of microscopic polyangiitis. Eur J Dermatol 2008; 19: 57-60. Go to original source...
    9. Ozaki S ANCA‑associated vasculitis: diagnostic and therapuetic strategy. Allergo Int 2007; 56: 87-96. Go to original source... Go to PubMed...
    10. Specks U, Merkel PA, Seo P et al. Efficacy of remission‑induction regimens for ANCA‑associated vasculitis. N Engl J Med 2013; 369: 417-427. Go to original source... Go to PubMed...
    11. Haraguchi K, Gunji K, Ito Y et al. Extensive pancreatic necrosis in microscopic polyangiitis. Clin Exp Nephrol 2005; 9: 326-331. Go to original source... Go to PubMed...
    12. Oh YJ, Ahn SS, Park ES et al. Chest and renal involvements, Birmingham vascular activity score more than 13.5 and five factor score more than 1 at diagnosis are significant predictors of relapse of microscopic polyangiitis. Clin Exp Rheumatol 2017; 19: 47-54.
    13. Agard C, Mouthon L, Mahr A et al. Microscopic Polyangiitis and Polyarteritis Nodosa: How and When Do They Start? Arthritis & Rheumatism 2003; 15: 709-715. Go to original source... Go to PubMed...
    14. Avery TY, Bons J, van Paassen P et al. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness. Lupus 2016; 31: 917-924. Go to original source... Go to PubMed...
    15. Veerappan I, Prabitha EN, Abraham A et al. Double ANCA‑positive vasculitis in a patient with infective endocarditis. Indian J Nephrol 2012; 22: 469-472. Go to original source... Go to PubMed...
    16. Langlois V, Marie I Antineutrophil cytoplasmic antibodies associated with infective endocarditis: Literature review. Rev Med Interne 2017; 38: 450-457. Go to original source... Go to PubMed...
    17. Tran H, Tan D, Marnejon TP et al. Cutaneous vasculopathy associated with levamisole‑adulterated cocaine. Clinical Medicine & Research 2013; 11: 26. 30. Go to original source... Go to PubMed...
    18. Yates M, Watts RA, Bajema IM et al. EULAR/ERA‑EDTA recommendations for the management of ANCA‑associated vasculitis. Ann Rheum Dis 2016; 75: 1583-1594. Go to original source... Go to PubMed...
    19. Tesar V, Hruskova Z Avacopan in the treatment of ANCA‑associated vasculitis. Expert Opin Investig Drugs 2018; 27: 491-496. Go to original source... Go to PubMed...
    20. Taha R, El‑Haddad H, Allmualim A et al. Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody‑associated vasculitis, hepatitis C virus‑related cryoglobulinemic vasculitis, Henoch‑Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomenon. Open Access Rheumatol 2017; 9: 201-214. Go to original source... Go to PubMed...
    21. Jones RB, Hiemstra TF, Ballarin J et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA‑associated vasculitis: a randomised, non‑inferiority trial. Ann Rheum Dis 2019; 78: 399-405. Go to original source... Go to PubMed...
    22. Cibičková Ľ, Soukup T, Tomš J et al. Centrální pravostranná hemiparéza jako dominující projev systémové vaskulitidy. Vnitř Lék 2010; 56: 1194-1197. Go to PubMed...
    23. Bradna P, Maňák J, Soukup T Difuzní alveolární hemoragie - akutní, život ohrožující stav v revmatologii. Vnitř Lék 2018; 64.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.